Michelson Diagnostics OCT scanner garners $955k investment

Michelson Diagnostics (Orpington, England) has gained a $955k investment for its VivoSight optical coherence tomography (OCT) scanners for non-melanoma skin cancer. Extending the £1.92M investment the scanners received in October 2011, the new investment will further expand sales and support infrastructure in both the US and Europe and comes from shareholders Octopus Investments, Catapult Venture Managers, and individual investors, including London Business Angels.

VivoSight—based on the company's patented multi-beam OCT technology—diagnoses and treats non-melanoma skin cancer noninvasively, enabling clinicians to 'see' under skin surface in real time while conserving healthy tissue. Able to reduce unnecessary surgery, the scanners have already earned CE and FDA regulatory clearance for clinical use in Europe and the US, respectively, and have entered commercial service at dermatology clinics in the US and Germany. In the future, the scanners could guide and monitor next-generation, noninvasive topical treatments for non-melanoma skin cancer currently in clinical development.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

OCT imaging improves percutaneous coronary intervention, study finds

OCT can visualize coronary arteries in patients undergoing percutaneous coronary intervention, leading to improved outcomes.

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS